Godlike Productions - Discussion Forum
Users Online Now: 2,168 (Who's On?)Visitors Today: 782,937
Pageviews Today: 1,381,911Threads Today: 585Posts Today: 10,121
04:03 PM


Back to Forum
Back to Forum
Back to Thread
Back to Thread
REPLY TO THREAD
Subject British woman, 39, dies in Cyprus in 'blood clotting incident' days after receiving AstraZeneca Covid-19 vaccine
User Name
 
 
Font color:  Font:








In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 50% of the source material, provide a link back to the original article and provide your original comments / criticism in your post with the article.
Original Message A 39-year-old British woman has died in a Cypriot hospital after a blood clotting incident after receiving the AstraZeneca Covid-19 vaccine.

Charalambos Charilaou, the spokesperson for the state health services, said the European Medicines Agency (EMA) would investigate the death.

The woman, treated at Nicosia General Hospital's intensive care unit, received the first dose of the vaccine on May 6 in the resort town of Paphos on the western coast of the Mediterranean island.


The woman, who was not named, suffered symptoms days later and died over the weekend. According to the Cyprus Mail newspaper, the woman suffered a brain haemorrhage and was in a coma before she died.

Cyprus health authorities have opened an investigation to see if the 'serious thrombotic episode' was linked to the AstraZeneca jab.


Cypriot authorities are investigating another four other cases of 'mild' blood clotting incidents - three of which occurred after an AstraZeneca shot and one after a Pfizer jab - are also being investigated by Cyprus.

Some countries have restricted or dropped AstraZeneca shots from national vaccine campaigns over very rare blood clots, though the EMA says the benefits outweigh the risks.

AstraZeneca is the backbone of the vaccination rollout in Cyprus, where family doctors also allowed to administer the jab to anybody aged over 20.

But many people booking online to get the vaccine have snubbed AstraZeneca and opted for other shots.

The Oxford-developed jab has been marred in controversy since the European Union's drug watchdog found a possible link between the vaccine and very rare blood clot cases in mid-April.

However it said the risk of dying from Covid-19 was 'much greater' than the risk of mortality from rare side effects, which affect around one in 100,000 people given the British-made jab.

Regulators have so far spotted major blood clots in 242 people, of whom 49 died, with more than 28million doses now administered.

The clots have so far occurred in 141 women and 100 men aged from 18 to 93, and the overall case death rate is 20 per cent.

They appear to be more common in younger adults and slightly more common in women.

[link to www.dailymail.co.uk (secure)]
Pictures (click to insert)
5ahidingiamwithranttomatowtf
bsflagIdol1hfbumpyodayeahsure
banana2burnitafros226rockonredface
pigchefabductwhateverpeacecool2tounge
 | Next Page >>





GLP